1. Home
  2. STXS vs NRO Comparison

STXS vs NRO Comparison

Compare STXS & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • NRO
  • Stock Information
  • Founded
  • STXS 1990
  • NRO 2003
  • Country
  • STXS United States
  • NRO United States
  • Employees
  • STXS N/A
  • NRO N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NRO Finance/Investors Services
  • Sector
  • STXS Health Care
  • NRO Finance
  • Exchange
  • STXS Nasdaq
  • NRO Nasdaq
  • Market Cap
  • STXS 151.3M
  • NRO 156.7M
  • IPO Year
  • STXS 2004
  • NRO N/A
  • Fundamental
  • Price
  • STXS $2.17
  • NRO $3.20
  • Analyst Decision
  • STXS
  • NRO
  • Analyst Count
  • STXS 0
  • NRO 0
  • Target Price
  • STXS N/A
  • NRO N/A
  • AVG Volume (30 Days)
  • STXS 270.0K
  • NRO 239.4K
  • Earning Date
  • STXS 08-11-2025
  • NRO 01-01-0001
  • Dividend Yield
  • STXS N/A
  • NRO 11.41%
  • EPS Growth
  • STXS N/A
  • NRO N/A
  • EPS
  • STXS N/A
  • NRO N/A
  • Revenue
  • STXS $27,510,000.00
  • NRO N/A
  • Revenue This Year
  • STXS $25.90
  • NRO N/A
  • Revenue Next Year
  • STXS $60.57
  • NRO N/A
  • P/E Ratio
  • STXS N/A
  • NRO N/A
  • Revenue Growth
  • STXS 1.50
  • NRO N/A
  • 52 Week Low
  • STXS $1.54
  • NRO $2.51
  • 52 Week High
  • STXS $2.72
  • NRO $3.45
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.27
  • NRO 51.58
  • Support Level
  • STXS $2.00
  • NRO $3.17
  • Resistance Level
  • STXS $2.36
  • NRO $3.27
  • Average True Range (ATR)
  • STXS 0.11
  • NRO 0.04
  • MACD
  • STXS -0.01
  • NRO -0.00
  • Stochastic Oscillator
  • STXS 50.00
  • NRO 58.33

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").

Share on Social Networks: